
Onconomics Extract Plus: Application of Precision Metabolite Detection in Cancer Care
Onconomics Extract Plus is an innovative blood testing technology introduced by RGCC (The Research Genetic Cancer Center) designed to provide early cancer detection, treatment monitoring, and personalized care by analyzing metabolites and biomarkers in the blood. This test identifies characteristic substances produced by tumor cells during metabolic processes, offering real-time diagnostic information and personalized care guidance for physicians. The Onconomics Extract Plus test enables a more precise understanding of cancer progression, treatment responses, and patient care.







